Proteomics Study on Cross-Linking Reaction of Formaldehyde and HSA

Article Preview

Abstract:

Possible clinical diagnosis biomarkers of diabetes were proposed using proteomics and bioinformatics methods through the preliminary study on the formaldehyde-human serum albumin crosslinkage. Using LC/MS techniques, the experiment on in vivo cross-linking reaction of formaldehyde with pure protein or plasma protein revealed that the cross-linking reaction of human serum albumin and forrmaldehyde would occur and the concentrations of some normal peptides would change. A group of significant peptides of human serum albumin were selected. As the results of in vivo cross-linking reaction, Non-enzymatic glycosylation modification of HSA were observed in diabetic. The same change of the concentrations of some peptides happened. The above-mentioned results were demonstrated with the hematoplasmas of normal people and diabetics.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 343-344)

Pages:

1035-1041

Citation:

Online since:

September 2011

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2012 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] Blau K. Chromatographic methods for the study of amines from biological material. Biochem J, 1961, 80: 193-200.

DOI: 10.1042/bj0800193

Google Scholar

[2] Baba S, Watanabe Y, Gejyo F, et al. High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin Chim Acta, 1984, 136: 49-56.

DOI: 10.1016/0009-8981(84)90246-8

Google Scholar

[3] Asatoor AM, Kerr DNS. Amines in blood and urine in relation to liver disease. Clin Chim Acta , 1961, 6: 149-156.

DOI: 10.1016/0009-8981(61)90078-x

Google Scholar

[4] Lyles GA, McDougall SA. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. Pharm Pharmacol J, 1989, 41: 97-100.

DOI: 10.1111/j.2042-7158.1989.tb06401.x

Google Scholar

[5] Smith AD, Jepson JB. Chromatography of urinary and tissue amines and amino alcohols as 2, 4-dinitrophenyl derivatives prepared with 2-nitrobenzenesulfonic acid. Anal Biochem, 1967, 18: 36-45.

DOI: 10.1016/0003-2697(67)90053-x

Google Scholar

[6] Schayer RW, Smiley LR, Kaplan HE. The metabolism of epinephrine containing isotopic carbon, Biol Chem J, 1952, 198: 545-551.

DOI: 10.1016/s0021-9258(18)55509-5

Google Scholar

[7] Dar MS, Morselli PL, Bowman ER. The enzymatic systems involved in the mammalian metabolism of methylamine. Gen Pharmacol, 1985, 16: 557-560.

DOI: 10.1016/0306-3623(85)90142-9

Google Scholar

[8] Zeisel SH, Dacosta KA. Increase in human exposure to methylamine precursors of N-nitrosamines after eating fish. Cancer Res, 1986, 46: 6136-6138.

Google Scholar

[9] US Dept Health and Human Services Constituents of tobacco smoke. USPHS Publication No. 82-50179, 1982, 322.

Google Scholar

[10] Bolt HM . Experimental toxicology of formaldehyde. J Cancer Res Clin Oncol , 1987, 113: 305–309.

Google Scholar

[11] Nilsson SE, Tryding N, Tufvesson G . Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med Scand 1968, 184: 105–108.

DOI: 10.1111/j.0954-6820.1968.tb02429.x

Google Scholar

[12] Yuen CT, Easton D, Misch K, et al. Increased activity of serum amine oxidase in granuloma annulare, necrobiosis lipoidics and diabetes. Br J Dermatol , 1987, 11: 643–649.

DOI: 10.1111/j.1365-2133.1987.tb05897.x

Google Scholar

[13] Boomsma F, Derkx FH, van den Meiracker AH, et al. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci, 1995, 88: 675– 679.

DOI: 10.1042/cs0880675

Google Scholar

[14] Garpenstrand H, Ekblom J, Backlund LB, et al. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in type 2 diabetes mellitus complicated by retinopathy. Diabet Med, 1999, 16: 514–521.

DOI: 10.1046/j.1464-5491.1999.00103.x

Google Scholar

[15] Ishizaki F. Plasma benzylamine oxidase activity in cerebrovascular disease. Eur Neurol, 1990, 30: 104–107.

DOI: 10.1159/000117321

Google Scholar

[16] Boomsma F, van Veldhuisen DJ, de Kam PJ, et al. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res, 1997, 33: 387–391.

DOI: 10.1016/s0008-6363(96)00209-x

Google Scholar

[17] Yu PH, Deng YL. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover. Atherosclerosis, 1998, 140: 357-363.

DOI: 10.1016/s0021-9150(98)00142-7

Google Scholar

[18] Helander A, Tottmar O. Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma. Biochem. Pharmacol, 1987, 36: 1077-1082.

DOI: 10.1016/0006-2952(87)90417-5

Google Scholar

[19] Malorny GN, Rietbrock N, Schneider M. The oxidation of formaldehyde to formic acid in the blood and contribution to the metabolism of formaldehyde, Naunynschmiedeberg's Arch. Exp. Pathol. Pharmakol, 1965, 250: 419-436.

Google Scholar

[20] Gubisne-Haberle D, Hill W, Kazachkov M, et al. Protein cross- linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther, 2004, 310: 1125-1132.

DOI: 10.1124/jpet.104.068601

Google Scholar